Topical propranolol for infantile hemangioma: a comprehensive review of mechanisms, clinical efficacy, and novel formulations. [PDF]
Chen F +10 more
europepmc +1 more source
Factors influencing treatment duration of oral propranolol in infantile hemangioma: a five-year retrospective analysis. [PDF]
Li Q +8 more
europepmc +1 more source
A Systematic Review of the Efficacy and Safety of Sirolimus (Rapamycin) in the Management of Infantile Hemangioma. [PDF]
Abtahi-Naeini B +3 more
europepmc +1 more source
Systemic angiogenic protein changes following propranolol therapy in infantile hemangioma: a multi-target perspective. [PDF]
Liang L +5 more
europepmc +1 more source
Management of infantile hemangiomas
openaire +2 more sources
RETRACTION: Our Experience With Propranolol for Infantile Hemangioma. [PDF]
europepmc +1 more source
Multi-omics unravels multiple pharmacological actions in a murine model of infantile hemangioma receiving oxymatrine therapy. [PDF]
Wang Y +6 more
europepmc +1 more source
Case Report: Hepatic infantile hemangioma malignantly transformed into hemangiosarcoma. [PDF]
Gu X, Tao Q, Lu Z, Liu J, Zhang Z, Lu C.
europepmc +1 more source
Decoding infantile hemangioma: cellular dynamics, molecular signals, and microenvironmental influences. [PDF]
Zhu Z, Jiang X, Wang F, Zhao L, Song Q.
europepmc +1 more source
Is it a hemangioma? A combined case report of soft tissue sarcomas mimicking infantile hemangioma. [PDF]
Almutairi S +5 more
europepmc +1 more source

